Viking Therapeutics
Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
VKTX Key Statistics
Stock Snapshot
The current Viking Therapeutics(VKTX) stock price is $28.77, with a market capitalization of 3.34B. The stock trades at a price-to-earnings (P/E) ratio of -6.93.
On 2026-06-14, Viking Therapeutics(VKTX) stock traded between a low of $28.50 and a high of $29.28. Shares are currently priced at $28.77, which is +1.0% above the low and -1.7% below the high.
Viking Therapeutics(VKTX) shares are trading with a volume of 1.18M, against a daily average of 2.11M.
During the past year, Viking Therapeutics(VKTX) stock moved between $22.96 at its lowest and $43.15 at its peak.
During the past year, Viking Therapeutics(VKTX) stock moved between $22.96 at its lowest and $43.15 at its peak.
VKTX News
...
(RTTNews) - Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company, Thursday announced that it has appointed Hubert Chen, as its Chief Med...
In the latest market close, Viking Therapeutics, Inc. (VKTX) reached $61.68, with a -1.03% movement compared to the previous day. The stock's performance was be...
Analyst ratings
89%
of 19 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.